QUESTION: Over the past few years since I started working with patients with major depression I have noticed an alarming number that have had a poor response to monotherapy antidepressants. What is the best pharmacological approach to treating treatment-resistant depression? DEBORAH ANTAI-OTONG RESPONDS: Treatment-resistant depression (TRD) is a relatively common, yet chronic, complicated, and disabling illness despite the broad range of treatment options available for depression. It is generally unrecognized and undertreated. Growing data challenge monotherapy antidepressant treatment as the sole option for depressed patients.
No takes yet. Share an insight, caveat, or question.
Deborah Antai-Otong (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Perspectives In Psychiatric Care